Efficacy of Aromatase Inhibitors in Postmenopausal Breast Cancer Patients

Breast cancer is commonly affecting cancer in women, and it is more common in postmenopausal women who have passed over 50 years of age. Even Though there are various advanced treatments involved in treating breast cancer, the aromatase inhibitor plays a vital role in treating breast cancer patients who have gone through the menopause stage.